PTX 2.56% 4.0¢ prescient therapeutics limited

Ann: PTX Acquires Worldwide License for Cancer Biomarker p27, page-3

  1. 1,232 Posts.
    lightbulb Created with Sketch. 178
    Personalised medicine...always a good place to position a company.

    Chemgenex might have made a better fist of commercialising Omapro if they had their companion diagnostic ready to go before the FDA asked for it. Would have helped their sale price too!

    The plan is coming together, and @$6m mkt cap the buy signals are starting to ring a little louder!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.1¢ 4.1¢ 4.0¢ $1.805K 44.51K

Buyers (Bids)

No. Vol. Price($)
9 489716 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 66951 1
View Market Depth
Last trade - 12.14pm 25/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.